Hahnemann University Hospital Named “Center of Excellence” 
Hahnemann's Department of Radiology was highlighted for their excellence in breast cancer treatment. 
PHILADELPHIA (May 10, 2010) - Hahnemann University Hospital was recently named a “Center of Excellence” in accelerated partial breast irradiation (APBI) for its use of the SAVI™ applicator, an advanced therapy for breast cancer as part of breast conservation therapy. The SAVI applicator can provide important advantages for women with early-stage breast cancer.

            Designation as a Center of Excellence recognizes Hahnemann’s dedication to education, training and experience in APBI. To qualify, Hahnemann’s physicians, medical physicists and clinical staff were required to complete a comprehensive training and education program in order to demonstrate proficiency in delivering radiation therapy with SAVI. As a Center of Excellence, Hahnemann has also expressed a commitment to patient education, advocacy and awareness of advanced breast cancer treatments.

Hahnemann’s commitment to offer the SAVI applicator may extend the benefits of breast conservation therapy to a larger group of women.

“We are very proud to be named a Center of Excellence by SAVI,” stated Lydia Komarnicky, M.D., clinical service chief, Department of Radiation Oncology, at Hahnemann University Hospital. “Our staff strives to provide the highest quality of care.”

Breast-conservation therapy includes lumpectomy– the surgical removal of the cancerous tissue within the breast plus tissue immediately around the tumor – followed by radiation. This approach is an alternative to mastectomy, which removes the entire breast and is often followed by breast reconstruction.

The SAVI technology was developed by Cianna Medical, Inc., (Aliso Viejo, Calif.) a women's health company dedicated to the early treatment of breast cancer.

About Hahnemann University Hospital

Hahnemann University Hospital is a 496-bed academic medical center at Broad and Vine Streets in Philadelphia, Pa.  The hospital is a tertiary care institution that specializes in cardiac services, heart failure and transplantation, OB/GYN, orthopedics, medical, surgical and radiation oncology, bone marrow transplantation, renal dialysis and kidney/pancreas/liver transplantation. In 2009, Hahnemann earned Magnet® designation by the American Nurses Credentialing Center (ANCC) Magnet Recognition Program®.  Hahnemann is recognized by the American Heart Association as a leader in coronary artery disease and heart failure treatments.   The hospital performed one of the city’s first kidney transplants in 1963 and one of the first bone marrow transplants in 1976.  Hahnemann became Philadelphia’s first Level I Regional Resource Trauma Center for adults in 1986, and since then has been served by MidAtlantic MedEvac, an aeromedical transport program for critically ill patients. Hahnemann is proud to be the first hospital in Philadelphia to join with The Wellness Community of Philadelphia to offer onsite support and education services to cancer patients and their families.  Hahnemann is fully accredited by the Joint Commission on the Accreditation of Healthcare Organizations, the nation’s oldest and largest hospital accreditation agency. An affiliate of Drexel University College of Medicine, Hahnemann University Hospital is part of Tenet Pennsylvania, which also includes St. Christopher’s Hospital for Children. To learn more about Hahnemann, visit www.hahnemannhospital.com    

Hahnemann University Hospital | 230 N Broad St, Philadelphia, PA 19102